News2018-11-16T12:40:52+00:00

LATEST NEWS

Lymphoseek®

HL Pharma is pleased to announce that it is the Sponsor and Distributor of Lymphoseek. Radiolabelled Lymphoseek is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity.

Novartis Partnership

HL Pharma is pleased to announce it is partnering with Novartis Australia to supply one of their ophthalmic products under The Special Access Scheme or Authorised Prescriber Scheme. This is until the Australian registered product becomes available.  

Glanatec (ripasudil) 0.4% Eye Drops

Glanatec (ripasudil) 0.4% Eye Drops Ripasudil is a Rho Kinase inhibitor, licensed in Japan. This product is not registered in Australia and is available for supply under The Special Access Scheme (SAS) C